Advertisement

Ads Placeholder
Loading...

Ionic Brands Corp.

IONC.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.005
$0.00(0.00%)
Canadian Market opens in 1h 0m

Ionic Brands Corp. (IONC.CN) Stock Competitors & Peer Comparison

See (IONC.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IONC.CNCA$0.01+0.00%727.6K-0.02-CA$0.33N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$7.48-3.61%2.8B12.68CA$0.59N/A
CURA.TOCA$3.36+8.04%2.6B-7.47-CA$0.45N/A
GTII.CNCA$9.70+6.59%2.2B14.48CA$0.67N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
TRUL.CNCA$8.48+4.69%1.4B-10.47-CA$0.81N/A
CRON.TOCA$3.52+1.15%1.3B-117.33-CA$0.03N/A
TLRY.TOCA$9.15+6.89%1.1B-0.45-CA$20.34N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IONC.CN vs CURA.CN Comparison April 2026

IONC.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IONC.CN stands at 727.6K. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, IONC.CN is priced at CA$0.01, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IONC.CN currently has a P/E ratio of -0.02, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, IONC.CN's ROE is -3.92%, compared to CURA.CN's ROE of -0.24%. Regarding short-term risk, IONC.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IONC.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions